1-8 of 8
Roy T Sabo, PhD
Close
Sort by
Journal Articles

The Use of Biomarker Ferritin and Albumin As Well As HCT-CI, but Not PAM, Was Predictive of Suvival, Gvhd and, Relapse in Myeloid Malignancies

Gary Simmons, DO, Allison F. Scalora, MS, Roy T Sabo, PhD, Catherine H. Roberts, PhD, William B. Clark, MD, Harold M. Chung, MD, Amir A. Toor, MD, John M. McCarty, MD
Journal: Blood
Blood (2015) 126 (23): 5448.
https://doi.org/10.1182/blood.V126.23.5448.5448
Published: 2015
Journal Articles

Lymphocyte Recovery Kinetics in Patients Undergoing Myeloablative Conditioning and Allogeneic Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Ali S Shubar Ali, BS, Catherine H. Roberts, PhD, Allison F Scalora, MS, Kristen M Kobulnicky, MS, Shiyu Song, MDPhD, William B. Clark, MD, Harold M. Chung, MD, John M. McCarty, MD, Michael C. Neale, PhD, Amir A. Toor, MD
Journal: Blood
Blood (2015) 126 (23): 5467.
https://doi.org/10.1182/blood.V126.23.5467.5467
Published: 2015
Journal Articles

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Radhika Thorn, MD, Jeremy Meier, BS, Elaine Wang, MD, Roy T Sabo, PhD, Allison F Scalora, MS, Catherine H Roberts, PhD, Shiyu Song, MD, PhD, Masoud H Manjili, DVM, PhD, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Amir A Toor, MD
Journal: Blood
Blood (2013) 122 (21): 4577.
https://doi.org/10.1182/blood.V122.21.4577.4577
Published: 2013
Journal Articles

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Allison F Scalora, MS, David Portier, MD, Devon Fletcher, MD, Jeffrey M Tessier, MD, William B Clark, MD, Harold M Chung, MD, John M McCarty, MD, Catherine H Roberts, PhD, Amir A Toor, MD
Journal: Blood
Blood (2013) 122 (21): 2071.
https://doi.org/10.1182/blood.V122.21.2071.2071
Published: 2013
Journal Articles

Optimizing Outcomes in Multiple Myeloma Using Risk Stratified Allocation to Single Versus Tandem Autologous SCT.

Matthew Risendal, BS, Roy T Sabo, PhD, Allison F Hazlett, MS, Priscilla Mpasi, BS, Joan Bolling, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Catherine H Roberts, PhD, Amir A Toor, MD
Journal: Blood
Blood (2012) 120 (21): 3123.
https://doi.org/10.1182/blood.V120.21.3123.3123
Published: 2012
Journal Articles

FLAG ± Idarubicin Compared with 7+3 As Initial Induction for Secondary Acute Myeloid Leukemia: A Single Institution Experience

Jenny Li, Pharm.D., BCPS, Mandy L Gatesman, Pharm.D., BCOP, Ashley M Newland, Pharm.D., BCOP, Roy T Sabo, PhD, Prithviraj Bose, MD
Journal: Blood
Blood (2012) 120 (21): 4330.
https://doi.org/10.1182/blood.V120.21.4330.4330
Published: 2012
Journal Articles

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Amir A Toor, MD, Roy T Sabo, PhD, Harold M Chung, MD, Catherine H Roberts, PhD, Rose H Manjili, BS, Shiyu Song, MD, PhD, David C. Williams, Jr., MD, PhD, William Clark, MD, Masoud H Manjili, DVM, PhD, John M McCarty, MD
Journal: Blood
Blood (2011) 118 (21): 3043.
https://doi.org/10.1182/blood.V118.21.3043.3043
Published: 2011
Journal Articles

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Amir A Toor, MD, Kyle Payne, BS, Harold M Chung, MD, Catherine H Roberts, PhD, Roy T Sabo, PhD, Maciej Kmieciak, PhD, William Clark, MD, Christy McLaughlin, BS, Angela Buskey, RN, Jennifer Anderson, RN, Rose H Manjili, BS, Susan D. Roseff, MD, John M McCarty, MD, Masoud H Manjili, DVM, PhD
Journal: Blood
Blood (2011) 118 (21): 2926.
https://doi.org/10.1182/blood.V118.21.2926.2926
Published: 2011